Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

AGM Statement

23 May 2007 11:49

Vernalis PLC23 May 2007 23 May 2007 VERNALIS PLC RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 23 MAY 2007 Vernalis plc announces that all resolutions proposed to shareholders at itsAnnual General Meeting held today were duly passed. All resolutions were approved on a show of hands. The number of proxy votesreceived for each resolution is set out below. Resolution For (including Against* Withheld discretionary votes)*Ordinary Resolution1. To receive theaudited accounts and related reports of theDirectors and auditors 224,569,857 (99.99%) 10,707 (0.01%) 7,1572. To approve theremuneration report 217,328,467 (99.63%) 813,306 (0.37%) 6,445,9483. To re-elect as a Director Dr A Baxter 224,545,392 (99.99%) 33,176 (0.01%) 9,1534. To re-elect as a Director Ms C C Ferguson 224,544,267 (99.98%) 38,844 (0.02%) 4,6105. To re-elect asa Director Mr J AD Slater 224,553,615 (99.99%) 28,646 (0.01%) 5,4606. To elect as aDirector Mr I Clark 224,542,703 (99.98%) 35,049 (0.02%) 9,9697. To re-appointPricewaterhouseCoopers LLP as auditors and to authorise the Directors to determine their remuneration 223,611,362 (99.65%) 792,957 (0.35%) 183,4028. To authorise the Directors to allot relevantsecurities 224,537,200 (99.98%) 37,797 (0.02%) 12,724Special Resolution9. To authorise the Directors to allot equitysecurities for cash 224,527,782 (99.98%) 39,519 (0.02%) 20,420Ordinary Resolution10. To approve the Vernalis plc Bonus Long-TermIncentive Plan 199,330,753 (91.39%) 18,789,501 (8.61%) 6,467,467 *NB: Percentage of votes cast excludes withheld votes Enquiries: Vernalis plc +44 (0)118 977 3133Simon Sturge, Chief Executive OfficerTony Weir, Chief Financial Officer Brunswick Group +44 (0)20 7404 5959Jon ColesAlex Tweed This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Sep 20137:00 amRNSAppointment of Nominated Advisor and Broker
26th Sep 201311:52 amRNSHolding(s) in Company
12th Sep 20135:41 pmRNSHolding(s) in Company
29th Jul 20134:00 pmRNSHolding(s) in Company
29th Jul 20137:00 amRNSInterim results for six months ended 30 June 2013
26th Jul 20135:45 pmRNSHolding(s) in Company
26th Jul 20135:10 pmRNSHolding(s) in Company
26th Jul 20134:48 pmRNSHolding(s) in Company
12th Jul 20137:00 amRNSVernalis Initiates Phase Ib/II POC Study of V81444
11th Jul 20137:00 amRNSNotice of Results for 6 months ended 30 June 2013
8th Jul 20133:17 pmRNSHolding(s) in Company
13th Jun 20137:00 amRNSFrovatriptan data to be presented at IHC
22nd May 201311:43 amRNSResult of AGM
29th Apr 20135:10 pmRNSHolding(s) in Company
26th Apr 201311:29 amRNSTransaction of Directors
19th Apr 201312:00 pmRNSTransaction by Directors
17th Apr 20139:22 amRNSNotice of Annual Report and AGM
16th Apr 201312:24 pmRNSTransactions of Directors/Applicable Employees
10th Apr 20137:00 amRNSAnnouncement of Results for year ended 31/12/12
21st Mar 20137:00 amRNSNotice of Results
19th Mar 20135:34 pmRNSHolding(s) in Company
6th Mar 20137:15 amRNSVernalis and Servier Extend Oncology Collaboration
6th Mar 20137:00 amRNSFirst Product in Cough Cold Pipeline Achieves POC
4th Mar 20137:00 amRNSVernalis received a further $2.5m from Genentech
8th Feb 20134:10 pmRNSHolding(s) in Company
4th Feb 20137:00 amRNSVernalis receives $1.5 m milestone from Genentech
7th Jan 20137:00 amRNSVernalis and Servier Achieve Research Milestone
2nd Jan 20138:36 amRNSVernalis and Lundbeck Achieve Third Milestone
12th Dec 20127:00 amRNSPositive Results Achieved in RO Study of V81444
20th Sep 20127:00 amRNSVernalis & Servier Achieve Research Milestone
4th Sep 20127:00 amRNSDirector/PDMR Shareholding
22nd Aug 20127:00 amRNSVernalis Initiates V81444 Receptor Occupancy Study
13th Aug 20127:00 amRNSVernalis to present at 14th World Congress on Pain
10th Aug 20122:56 pmRNSHolding(s) in Company
1st Aug 20127:00 amRNSInterim Results for six months ended 30 June 2012
10th Jul 201210:00 amRNSNotice of Results
1st Jun 201210:00 amRNSAUY922 Abstracts Accepted for Presentation at ASCO
30th May 20127:46 amRNSDirector/Applicable Employee Shareholding
22nd May 201212:50 pmRNSResult of AGM
2nd May 20127:00 amRNSSuccessful Outcome for V81444 in Phase I Study
27th Apr 20128:00 amRNSCancellation Vernalis Plc
27th Apr 20127:00 amRNSADMISSION OF SHARES TO AIM
26th Apr 20125:38 pmRNSChange of Registered Office
25th Apr 20127:00 amRNSVernalis and Servier Achieve Research Milestone
18th Apr 20125:05 pmRNSNotice of Annual Report and Annual General Meeting
3rd Apr 20127:00 amRNSAnnouncement of Results year ended 31 Dec 2011
27th Mar 20127:00 amRNSSchedule 1 - Vernalis plc
27th Mar 20127:00 amRNSCancellation of Listing/Proposed Admission to AIM
14th Mar 20127:00 amRNSNotice of Results
9th Mar 20125:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.